Laurence J. Blumberg
Founder at Syntimmune, Inc.
Laurence J. Blumberg active positions
| Companies | Position | Start | End |
|---|---|---|---|
AFB Fund LLC
 AFB Fund LLC Investment Trusts/Mutual FundsMiscellaneous AFB Fund LLC provides fund and sub-fund services. It offers general, designated, restricted and auxiliary fund services. The company is headquartered in Tenafly, NJ. | Corporate Officer/Principal | - | - |
| Blumberg Capital Advisors LLC | Corporate Officer/Principal | 03/05/2011 | - |
| Director/Board Member | - | 03/05/2011 | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Director/Board Member | 31/12/2012 | - |
| Founder | 31/12/2012 | - | |
| Chief Executive Officer | 31/12/2012 | - | |
| Chief Operating Officer | 31/12/2012 | - | |
| President | 31/12/2012 | - | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Director/Board Member | 06/04/2021 | - |
| Chief Executive Officer | 06/04/2021 | - | |
| President | 06/04/2021 | - |
Career history of Laurence J. Blumberg
Former positions of Laurence J. Blumberg
| Companies | Position | Start | End |
|---|---|---|---|
| CAMBRIDGE HEART, INC. | Director/Board Member | 31/12/2007 | 31/12/2007 |
Blumberg Capital Management LLC
 Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Analyst-Equity | - | 30/07/2007 |
| Chief Investment Officer | - | 30/07/2007 | |
| Portfolio Manager-Equities | - | 30/07/2007 | |
| President | - | 30/07/2007 | |
Alliance Capital Corp.
 Alliance Capital Corp. Finance/Rental/LeasingFinance Alliance Capital Corp. provides equipment financing and leasing services. It offers capital, operating, TRAC lease services. The company was founded in 1995 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | 31/12/1993 | - |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Director/Board Member | 31/12/1998 | - |
| Founder | 26/04/2011 | - |
Training of Laurence J. Blumberg
| Brandeis University | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Temple University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 13 |
Operational
| Director/Board Member | 5 |
| Corporate Officer/Principal | 4 |
| President | 3 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 9 |
|---|---|
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Finance |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
AFB Fund LLC
AFB Fund LLC Investment Trusts/Mutual FundsMiscellaneous AFB Fund LLC provides fund and sub-fund services. It offers general, designated, restricted and auxiliary fund services. The company is headquartered in Tenafly, NJ. | Miscellaneous |
| Blumberg Capital Advisors LLC | |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
Cambridge Heart, Inc.
 Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Cambridge Heart, Inc. engages in the development and commercialization of products for the non-invasive diagnosis of cardiac disease. The company was founded by Jeffrey M. Arnold and Jordan S. Davis on January 16, 1990 and is headquartered in Tewksbury, MA. | Health Technology |
Alliance Capital Corp.
Alliance Capital Corp. Finance/Rental/LeasingFinance Alliance Capital Corp. provides equipment financing and leasing services. It offers capital, operating, TRAC lease services. The company was founded in 1995 and is headquartered in Minneapolis, MN. | Finance |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Health Technology |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
- Stock Market
- Insiders
- Laurence J. Blumberg
- Experience
